Completed NA INTERVENTIONAL 2-arm NCT04114916

Clinical Trial to Evaluate the Reduction of Cardiovascular Risk (NUT)

Clinical Trial to Evaluate the Efficacy of a Nutraceutical Versus Placebo in Reducing Cardiovascular Risk in Healthy Subjects.

Sponsor: Universidad Católica San Antonio de Murcia

Conditions Cholesterol

Interventions Apigenin, luteonin, grapefruit extract and citrolive maltodextrina

Updated 4 times since 2019 Last updated: Oct 1, 2019 Started: Oct 1, 2016 Primary completion: Dec 22, 2018 Completion: Dec 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04114916, this NA trial focuses on Cholesterol and remains completed. Sponsored by Universidad Católica San Antonio de Murcia, it has been updated 4 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2019 — Jan 2021 [monthly]

Completed NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Católica San Antonio de Murcia

Data source: Universidad Católica San Antonio de Murcia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain